Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSF1R | P07333 | 13/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | CRHR1 | P34998 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6867755 | 0.80 | KMT2A (0.44) | CSF1RGAAALDH1A1MEN1KMT2A | |
| SCHEMBL6880340 | 0.80 | ALDH1A1 (0.40) | GAAALDH1A1CYP3A4MEN1MAPT | |
| SCHEMBL6875789 | 0.79 | HTT (0.39) | CSF1RALDH1A1MEN1THRBKMT2A | |
| SCHEMBL6875792 | 0.78 | CSF1R (0.38) | CSF1RMEN1KMT2A | |
| SCHEMBL26515870 | 0.73 | CRHR1 (0.47) | CSF1RCRHR1 | |
| SCHEMBL21256824 | 0.72 | CSF1R (0.39) | CSF1RALDH1A1 | |
| SCHEMBL26515762 | 0.72 | CRHR1 (0.42) | CSF1RTHRBCRHR1 | |
| SCHEMBL1239049 | 0.70 | MAPK1 (0.41) | ALDH1A1MEN1MAPTKMT2A | |
| SCHEMBL4766178 | 0.70 | TUBB4A (0.50) | CSF1RGAAALDH1A1CYP3A4MEN1 | |
| SCHEMBL6875492 | 0.70 | GAA (0.46) | GAAALDH1A1CYP3A4MEN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6713499-B2 | ADENOSINE RECEPTOR AGONIST | HOFFMAN-LA ROCHE INC. | 2004-03-30 | — | — | US | disclosed |
| US-20030153566-A1 | 7-Amino-benzothiazole derivatives | F. HOFFMANN-LA ROCHE AG (CH) | 2003-08-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030153566-A1 | 7-Amino-benzothiazole derivatives | ADORA1, ADORA2A, ADORA3 | CSF1R 718/4885GAA 2652/4885ALDH1A1 308/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.